\u4eca\u9031\u306f\u3001\u5148\u9031\u4e88\u544a\u3057\u305f\u901a\u308a\u30c9\u30a4\u30c4\u30fb\u30d9\u30eb\u30ea\u30f3\u533b\u79d1\u5927\u5b66\u75c5\u9662\u3067\u3042\u308bCharit\u00e9\u306eweb site\u304b\u3089\u3001\u3053\u3053\u3067\u958b\u767a\u3055\u308c\u305f\u3044\u308d\u3044\u308d\u306a\u6cbb\u7642\u6cd5\u306e\u30cb\u30e5\u30fc\u30b9\u306b\u3064\u3044\u3066\u307f\u3066\u3044\u304d\u307e\u3057\u3087\u3046\u3002\u3053\u3053\u306f\u30e8\u30fc\u30ed\u30c3\u30d1\u6700\u5927\u306e\u5927\u5b66\u75c5\u9662\u3060\u305d\u3046\u3067\u3059\u3002
\n\u4e00\u3064\u76ee\u306f\u3001\u91cd\u75c7\u306e\u81a0\u539f\u75c5\uff08\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\uff09\u306e23\u624d\u306e\u5973\u6027\u304c\u30ac\u30f3\u306e\u85ac\u306e\u6295\u4e0e\u3067\u75c7\u72b6\u304c\u6d88\u3048\u305f\u3068\u3044\u3046\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\u3053\u306e\u75c5\u6c17\u306f\u65e5\u672c\u3067\u30826~10\u4e07\u4eba\u306e\u60a3\u8005\u304c\u3044\u308b\u6307\u5b9a\u96e3\u75c5\u3067\u3001\u6cbb\u7642\u6cd5\u304c\u958b\u767a\u3055\u308c\u308c\u3070\u6717\u5831\u3067\u3059\u3002
\nhttps:\/\/www.charite.de\/en\/service\/press_reports\/artikel\/detail\/impressive_results_against_autoimmune_disease\/
\n\u6295\u4e0e\u3055\u308c\u305f\u85ac\u306fTeclistamab\u3068\u3044\u3046\u30e2\u30ce\u30af\u30ed\u2015\u30ca\u30eb\u6297\u4f53\u3067\u3059\u3002\u5316\u5b66\u5f0f\u306fC6383 H9847 N1695 O2003 S40\u3067\u3001\u5206\u5b50\u91cf\u306f143662\u3060\u305d\u3046\u3067\u3059\u3002\u5de8\u5927\u5206\u5b50\u3067\u3059\u304c\u3001\u7cbe\u5bc6\u306b\u5206\u5b50\u69cb\u9020\u304c\u898f\u5b9a\u3055\u308c\u3066\u751f\u7269\u7684\u306b\u5408\u6210\u3055\u308c\u308b\u85ac\u3067\u3059\u306d\u3002\u4eca\u306e\u5408\u6210\u6cd5\u306f\u3088\u304f\u308f\u304b\u308a\u307e\u305b\u3093\u304c\u300130\u5e74\u524d\u306b\u898b\u5b66\u3057\u305f\u4f1a\u793e\u3067\u306f\u30e9\u30c3\u30c8\u306b\u76ee\u7684\u5206\u5b50\u3092\u4f5c\u308b\u3088\u3046\u306b\u907a\u4f1d\u5b50\u6539\u5909\u3057\u305f\u30d2\u30c8\u306e\u30ac\u30f3\u7d30\u80de\u3092\u57cb\u3081\u8fbc\u3093\u3067\u3001\u5927\u304d\u304f\u306a\u3063\u305f\u3089\u5207\u9664\u3057\u3066\u76ee\u7684\u5206\u5b50\u3092\u7cbe\u88fd\u3059\u308b\u3068\u3044\u3046\u65b9\u6cd5\u3067\u4f5c\u3063\u3066\u3044\u307e\u3057\u305f\u3002\u73fe\u5728\u306e\u3068\u3053\u308d\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e\u85ac\u3067\u3059\u304c\u3001\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306b\u805e\u304f\u306e\u306f\u9a5a\u304d\u3067\u3059\u3002\u3053\u306e\u85ac\u306f\u65e5\u672c\u3067\u306f\u672a\u8a8d\u53ef\u306e\u3088\u3046\u3067\u3059\u3002\u7c73Johnson&Johnson\u5098\u4e0b\u306eJanssen Pharmaceutical Companies\u304c\u958b\u767a\u3057\u307e\u3057\u305f\u3002
\n\u30ea\u30f3\u30d1\u7403\u306e\u4e00\u7a2e\u3067\u3042\u308bT\u7d30\u80de\u306eCD3\u3068B\u7d30\u80de\u306eBCMA (B-cell maturation antigen,\u5225\u540d \u816b\u760d\u58ca\u6b7b\u56e0\u5b5017)\u306b\u7d50\u5408\u3057\u307e\u3059\u3002
\nhttps:\/\/en.wikipedia.org\/wiki\/CD3_(immunology)
\nhttps:\/\/en.wikipedia.org\/wiki\/B-cell_maturation_antigen
\n\u4e0a\u8a18\u8a18\u4e8b\u306b\u3088\u308b\u3068\u3001Teclistamab\u306fB\u7d30\u80de\u304c\u5206\u5316\u3057\u3066\u6297\u4f53\u3092\u5206\u6ccc\u3059\u308bplasma cell (\u5f62\u8cea\u7d30\u80de)\u306e\u7523\u751f\u3092\u6b62\u3081\u308b\u50cd\u304d\u304c\u3042\u308b\u306e\u3067\u3001\u81a0\u539f\u75c5\u3067B\u7d30\u80de\u304c\u8aa4\u3063\u3066\u5927\u91cf\u306b\u4f5c\u3063\u3066\u3057\u307e\u3046\u81ea\u5df1\u6297\u4f53\u306e\u7523\u751f\u304c\u3068\u307e\u308b\u306e\u3067\u306f\u306a\u3044\u304b\u3001\u3068\u3044\u3046\u30a2\u30a4\u30c7\u30a2\u3067\u3001\u4ed6\u306b\u6cbb\u7642\u65b9\u6cd5\u306e\u306a\u3044\u91cd\u75c7\u60a3\u8005\u306b\u6295\u4e0e\u3057\u305f\u3089\u5287\u7684\u306b\u52b9\u3044\u305f\u3068\u3044\u3046\u3053\u3068\u3067\u3059\u3002\u3059\u3067\u306bCD20\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u3067\u3042\u308b\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u304c\u81a0\u539f\u75c5\u306e\u6cbb\u7642\u306b\u5b9f\u7528\u5316\u3055\u308c\u3066\u3044\u308b\u305d\u3046\u3067\u3059\u304c\u3001\u305d\u308c\u304c\u52b9\u304b\u306a\u3044\u4eba\u306b\u5225\u306e\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u304c\u52b9\u3044\u305f\u3068\u3044\u3046\u8a71\u3067\u3059\u306d\u3002\u30d2\u30c8\u578b\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u306f\u9ad8\u4fa1\uff08\uff5e3000\u4e07\u5186\uff09\u3060\u3068\u805e\u3044\u3066\u3044\u307e\u3059\u304c\u3001\u5c06\u6765\u306e\u9577\u3044\u82e5\u3044\u4eba\u3092\u6cbb\u305b\u308b\u306a\u3089\u3070\u63a8\u9032\u3059\u3079\u304d\u6cbb\u7642\u3060\u3068\u601d\u3044\u307e\u3059\u3002<\/p>\n
\u82f1\u8a9e\u306f\u9069\u5f53\u306b\u62fe\u3063\u3066\u307f\u307e\u3059\u3002
\nmultiple myeloma \u591a\u767a\u7684\u9aa8\u9ac4\u816b
\n–mab\u3068\u3044\u3046\u306e\u306f\u6297\u4f53\u533b\u85ac\u54c1\u3092\u8868\u3059\u63a5\u5c3e\u8f9e\u3067\u3059\u3002
\nmaturation\u3000\u6210\u719f
\ntumor \u816b\u760d
\nnecrosis \u58ca\u6b7b
\nfactor \u56e0\u5b50
\nsystemic \u5168\u8eab\u6027
\nrheumatology \u30ea\u30e5\u30fc\u30de\u30c1\u5b66
\nconnective tissue disease\/disorder \u81a0\u539f\u75c5<\/p>\n","protected":false},"excerpt":{"rendered":"
\u4eca\u9031\u306f\u3001\u5148\u9031\u4e88\u544a\u3057\u305f\u901a\u308a\u30c9\u30a4\u30c4\u30fb\u30d9\u30eb\u30ea\u30f3\u533b\u79d1\u5927\u5b66\u75c5\u9662\u3067\u3042\u308bCharit\u00e9\u306eweb site\u304b\u3089\u3001\u3053\u3053\u3067\u958b\u767a\u3055\u308c\u305f\u3044\u308d\u3044\u308d\u306a\u6cbb\u7642\u6cd5\u306e\u30cb\u30e5\u30fc\u30b9\u306b\u3064\u3044\u3066\u307f\u3066\u3044\u304d\u307e\u3057\u3087\u3046\u3002\u3053\u3053\u306f\u30e8\u30fc\u30ed\u30c3\u30d1\u6700\u5927\u306e\u5927\u5b66\u75c5\u9662\u3060\u305d\u3046\u3067\u3059\u3002 \u4e00\u3064\u76ee\u306f\u3001\u91cd\u75c7\u306e\u81a0\u539f\u75c5\uff08\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\uff09\u306e23\u624d\u306e\u5973\u6027\u304c\u30ac\u30f3\u306e\u85ac\u306e\u6295\u4e0e\u3067\u75c7\u72b6\u304c\u6d88\u3048\u305f\u3068\u3044\u3046\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\u3053\u306e\u75c5\u6c17\u306f\u65e5\u672c\u3067\u30826~10\u4e07\u4eba\u306e\u60a3\u8005\u304c\u3044\u308b\u6307\u5b9a\u96e3\u75c5\u3067\u3001\u6cbb\u7642\u6cd5\u304c\u958b\u767a\u3055\u308c\u308c\u3070\u6717\u5831\u3067\u3059\u3002 https:\/\/www.charite.de\/en\/service\/press_reports\/artikel\/detail\/impressive_results_against_autoimm…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[47],"tags":[10],"class_list":["post-2141","post","type-post","status-publish","format-standard","hentry","category-worldresearchinstitutes","tag-worldresearchinstitutes"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=\/wp\/v2\/posts\/2141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2141"}],"version-history":[{"count":0,"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=\/wp\/v2\/posts\/2141\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sekaiken.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}